HETEROGENEITY IN EFFICACY OF ROLOFYLLINE USING A RISK-BASED EVALUATION IN PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE

There is substantial variation in the etiology, clinical presentation and pathophysiology of patients hospitalized for acute heart failure (AHF) that may influence their natural history and response to therapy. We performed a post-hoc analysis of the PROTECT trial that compared rolofylline, a